Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.340264
Title: Transcription and cell cycle control
Author: France, Stephen Andrew
ISNI:       0000 0001 3481 5230
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 2000
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
The antiproliferative effects of the tumour suppressor p53 stem from its ability to induce either cell cycle arrest or apoptosis and are regulated by the p300/CBP transcriptional co-activator proteins. In order to elucidate the mechanisms of p300 dependent transcriptional activation of the p53 response, the role of a newly identified protein co-factor, termed JMY, that physically associates with p300 was examined. JMY effectively assists p300 in p53-dependent transactivation of apoptotic promoting genes. Removal of the proline rich domain in the C-terminus of JMY produces a protein that switches the functional outcome of the p53 response from apoptosis to cell cycle arrest. Results presented here suggest that JMY collaborates with p300 to stimulate p53 apoptosis while the JMYDeltaP isoform collaborates with p300 to induce p53 transactivation of p21[Wafl/Cip1] and cell cycle arrest. Thus, the proline rich region of JMY modulates p53's role as a cell cycle arrest or apoptotic inducing protein. Furthermore, JMY may functionally impact on the p53 pathway through its ability to associate with and influence the activities of human p14[ARF]. JMY co-activates and assists p300 in E2F-1 mediated expression of p14[arf]. In addition JMY is present in the p14[ARF] complex and a functional consequence of the interaction is the displacing of the nucleolar population of p14[ARF] into the nucleoplasm. A tumour derived mutant of pRb, pRbDelta22, that has lost E2F regulatory activity collaborates with JMY in the co-activation of p53-dependent Bax expression, suggesting that cells can by-pass the loss of growth control through pRb by stimulating apoptosis. JMY therefore acts as a potential regulator of the p53 response and may represent a novel target for the development of therapeutically useful modulators of p53 activity. Defining the mechanism through which JMY and pRb collaborate in apoptosis may prove useful in the understanding of the cells response to tumourigenesis.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.340264  DOI: Not available
Keywords: Genetics
Share: